期刊文献+

HSV-gB、gD糖蛋白重组串联抗原表位蛋白的表达及鉴定 被引量:1

Expression and Characterization of the Recombinant Epitopes of HSV-gB and HSV-gD Protein
下载PDF
导出
摘要 目的制备HSV-gB、gD蛋白串联表位重组蛋白,为单纯疱疹病毒(HSV)疫苗的研制提供新型抗原蛋白以及新的抗原制备方法。方法应用生物信息学软件laser gene DNASTAR分析HSV1-gB、gD和HSV2-gB、gD蛋白的抗原表位。选取9个表位,设计并合成表位串联重组蛋白编码基因X,构建其原核细胞表达重组体,在大肠杆菌BL21(DE3)表达该重组表位蛋白X,Western blot法(抗His标签)鉴定重组蛋白。结果构建了HSV-gB、gD蛋白串联表位重组蛋白X的原核表达体,在BL21菌中表达了X蛋白,Western blot法(抗His标签)鉴定了重组蛋白X。结论建立了制备HSV-gB、gD蛋白重组抗原表位蛋白的方法,为HSV疫苗的研制提供了可能的新型抗原蛋白。 Objective To prepare the recombinant epitopes of HSV-gB and HSV-gD protein and provides a new antigen protein for the development of herpes simplex virus (HSV)vaccine. Methods The epitopes of HSV-gB and HSV-gD protein were analyzed by epitope prediction software. A novel gene named X which encoded 9 predicted epitopes of HSV-Gb and HSV-gD protein was designed and synthesized using chemical method. X gene was cloned into vector PET-28a (+),expressed in Escherichia coli BL21 (DE3),and analyzed by Western blot. Results X gene was successfully designed and expressed in Escherichia coli BL21(DE3). Western blot analysis showed that recombinant X protein,which was with His marker,can be detected by anti-His antibody. Conclusion In this study we establish a new method to express recombinant epitope protein,which may be a new protein for developing vaccine against HSV infection.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2010年第3期181-183,共3页 Journal of China Medical University
关键词 单纯疱疹病毒 gB糖蛋白 gD糖蛋白 表位 抗原 herpes simplex virus gB glycoprotein gD glycoprotein epitope antigen
  • 相关文献

参考文献7

  • 1Kaufman HE,Azcuy AM ,Barnell ED,et al. HSV-1 DNA in tears and saliva of normal adults [ J ]. Invest Ophthahnol Vis Sei, 2005,46( 1 ) : 241-247.
  • 2Rajeani J,Durmanova V. Developments in herpes simplex virus vaccines:old problems and new challenges [J]. Folia Microbiol (Praha) ,2006,51 (2) :67-85.
  • 3Spear PG. Herpes simplex virus : receptors and ligands for cell entry. [J]. Cell Microbiol, 2004,101(50) :401-410.
  • 4房凯,钟连声,马汝海,王绍成,潘忠诚,张玉魁,何群,赵雨杰.SARS-CoV S蛋白表位的表达及鉴定[J].细胞与分子免疫学杂志,2007,23(11):1007-1009. 被引量:1
  • 5McGeoch D J, Dolan A, Jamieson FE, et al. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses [J]. Mol Biol, 1995,247(3) :443-458.
  • 6Stanberry LR,Spruance SL,Cunningham AL,et al. Glycoprotein-D- adjuvant vaccine to prevent genital herpes [J]. N Engl Med,2002, 347(21 ) : 1652-1661.
  • 7李建国,袁育康,范桂香,王军阳,任会勋,冯捷,马可为.单纯疱疹病毒1型糖蛋白D核酸疫苗的构建及初步免疫观察[J].西安医科大学学报,2001,22(4):304-307. 被引量:7

二级参考文献8

  • 1Kuba K,Imai Y,Rao S,et al.A crucial role of angiotensin converting enzyme 1 (ACE2) in SARS coronavirus-induced lung injury[J].Nature Medicine,2005,8(11):875 -879.
  • 2Jiang S,He Y,Liu S.SARS vaccine development[J].Emerg Infect Dis,2005,11(7):1016-1020.
  • 3He Y,Zhou Y,Siddiqui P,et al.Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry[J].BBRC,2004,325(2):445 -452.
  • 4Wang D,Lu J.Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV[J].Physiol Genomics,2004,18(2):245 -248.
  • 5Rota PA,Oberste MS,Monroe SS,et al.Characterization of a novel coronavirus associated with severe acute respiratory syndrome[J].Science,2003,300(5624):1394-1399.
  • 6Wong SK,Li W,Moore MJ,et al.A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2[J].J Biol Chem,2004,279(5):3197-3201.
  • 7周生华.DNA免疫的基础研究进展[J].国外医学(微生物学分册),1998,21(1):1-4. 被引量:3
  • 8董学员,杨小昂,李燕,徐国宾,冯珍如,王月丹,陈慰峰.SARS病毒S2基因的克隆、表达、纯化及其免疫学特性研究[J].细胞与分子免疫学杂志,2004,20(3):257-260. 被引量:10

共引文献6

同被引文献9

  • 1Rowe AM, St Leger A J, Jeon S, et al. Herpes keratitis [ J ]. Prog Reti- nal Eye Res,2013,32 : 88-101.
  • 2Royer DJ, Cohen A, Carr D. The current state of vaccine develop- ment for ocular HSV- 1 infection [J]. Expert Rev Ophthalmol, 2015, 10(2) : 113-126.
  • 3Ghiasi H, Hofman FM, Cai S, et al.Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV- 1 challenge of vaccinated mice [J]. Vaccine, 1999, 17(20-21 ) :2576-2582.
  • 4Durmanova V, Mosko T, Sapak M, et al. Efficacy of recombinant her- pes simplex virus 1 glycoprotein D candidate vaccines in mice [J ]. Acta Microbiol Immunol Hung, 2006,53 (4) : 459-477.
  • 5Caselli E, Balboni PG, Incorvaia C, et al. Local and systemic inocu- lation of DNA or protein gBls-based vaccines induce a protective immunity against rabbit ocular HSV- 1 infection [ J ]. Vaccine, 2000, 19(9-10) : 1225-1231.
  • 6James SH, Kimberlin DW, Whitley RJ. Antiviral therapy for herpes- virus central nervous system infections: neonatal herpes simplex vi- rus infection, herpes simplex encephalitis, and congenital cytomega- lovirus infection [ J ]. Antiviral Res, 2009,83 ( 3 ) : 207-213.
  • 7De Groot AS, Sbai H, Aubin CS, et al. Immuno-informatics : mining genomes for vaccine components [J]. hnmunol Cell Biol, 2002,80 ( 3 ) : 255-269.
  • 8关瑞娟,亢泽峰,李凌.HSK的包膜糖蛋白gB和gD与疫苗的研究新进展[J].国际眼科杂志,2012,12(6):1076-1077. 被引量:1
  • 9苏艳,王世民,邵俊高,张宝江,韦海娜.Kozak序列对金黄色葡萄球菌黏附因子FnBPA-A DNA疫苗诱导小鼠免疫应答的影响[J].生物工程学报,2013,29(4):458-465. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部